2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
187
Myelodysplastic Syndromes
82
Leukemia
39
Leukemia, Myelomonocytic, Chronic
36
Recurrence
24
Myeloproliferative Disorders
15
Congenital Abnormalities
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, Large B-Cell, Diffuse
13
Neoplasms
11
Primary Myelofibrosis
9
Melanoma
9
Blast Crisis
9
Thrombocythemia, Essential
7
Polycythemia Vera
7
Leukemia, Myelomonocytic, Acute
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Leukemia, Monocytic, Acute
7
Hodgkin Disease
7
Carcinoma, Non-Small-Cell Lung
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Ovarian Neoplasms
6
Myelodysplastic-Myeloproliferative Diseases
6
Anemia, Refractory, with Excess of Blasts
6
Neoplasm Metastasis
5
Lymphoma
5
Leukemia, Myeloid, Accelerated Phase
5
Leukemia, Biphenotypic, Acute
5
Lymphoma, Non-Hodgkin
4
Lung Neoplasms
4
Interventions
Gemcitabine
685
130-nm albumin-bound paclitaxel
199
Fluorouracil
190
Oxaliplatin
177
Albumin-Bound Paclitaxel
154
Capecitabine
137
Leucovorin
133
Irinotecan
114
Radiotherapy
96
Taxes
85
pembrolizumab
81
Cisplatin
73
Erlotinib Hydrochloride
70
Radiosurgery
69
Nivolumab
56
Drug Therapy
56
Bevacizumab
54
Magnetic Resonance Spectroscopy
51
Cyclophosphamide
50
folfirinox
45
Specimen Handling
43
Docetaxel
42
Cetuximab
40
Biopsy
39
irinotecan sucrosofate
38
S 1 (combination)
36
Pancreaticoduodenectomy
35
Blood Specimen Collection
34
Surgical Procedures, Operative
31
Paclitaxel
30
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
Decitabine
×
Clear all
NCT02685228
2016-02-18
SLOWDOSE001
The First Hospital of Jilin University
Phase NA
Unknown
20 enrolled